Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01744574 · ClinicalTrials.gov registry record · NA

Sex Differences, Hormones & Smoking Cessation

A NA study of Tobacco Cessation, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
216
Enrollment target
1
Study location

NCT01744574 is a NA study of Tobacco Cessation that has completed, run by University of Minnesota. The registered enrollment target is 216 participants, below the 1,643-participant average among 8 other Tobacco Cessation trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01744574, a NA study of Tobacco Cessation, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
216 participants
Enrollment target
1
Study location

Study Summary

Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in Project I we are proposing a double-blind randomized controlled trial to assess the role of exogenous progesterone on impulsivity and smoking cessation in a sample of males and females who are motivated to quit smoking.

Conditions Studied

Interventions

  • OTHER Placebo
  • DRUG Progesterone
  • OTHER Smoking Cessation Behavioral Counseling

Study Locations (1)

Minnesota

  • Delaware Clinical Research Unit, University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2012-12
Est. Completion 2017-07-27
Phase NA

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT01744574

The ClinicalTrials.gov registry entry for NCT01744574 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 216 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,643-participant average among 8 other Tobacco Cessation trials with a reported enrollment target (87% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Cessation appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT01744574 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01744574 about?

NCT01744574 is a clinical study titled "Sex Differences, Hormones & Smoking Cessation". Data suggest that progesterone may improve smoking cessation outcomes perhaps by reducing impulsive behavior. However, the clinical literature on this topic is lacking. Therefore, in Project I we are proposing a double-blind randomized controlled trial to assess the role of exogenous progesterone on...

What is the current status of trial NCT01744574?

This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2012-12. Estimated completion is 2017-07-27.

What conditions does trial NCT01744574 study?

This clinical trial studies the following conditions: Tobacco Cessation.

What interventions are being tested in trial NCT01744574?

The interventions under investigation include: Placebo (OTHER), Progesterone (DRUG), Smoking Cessation Behavioral Counseling (OTHER).

Who is sponsoring clinical trial NCT01744574?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01744574 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.